93 related articles for article (PubMed ID: 12903247)
1. Synthesis and structure-activity relationships of selective ligands for P3 purinoceptor-like protein (P3LP).
Umino T; Yoshioka K; Saitoh Y; Minakawa N; Nakata H; Matsuda A
Nucleic Acids Symp Ser; 2000; (44):19-20. PubMed ID: 12903247
[TBL] [Abstract][Full Text] [Related]
2. Nucleosides and nucleotides. 200. Reinvestigation of 5'-N-ethylcarboxamidoadenosine derivatives: structure-activity relationships for P(3) purinoceptor-like proteins.
Umino T; Yoshioka K; Saitoh Y; Minakawa N; Nakata H; Matsuda A
J Med Chem; 2001 Jan; 44(2):208-14. PubMed ID: 11170630
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of a unique adenosine binding site in rat brain using a selective ligand.
Yoshioka K; Matsuda A; Nakata H
Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):278-84. PubMed ID: 11251640
[TBL] [Abstract][Full Text] [Related]
4. Nucleosides and nucleotides. 177. 9-(6,7-dideoxy-beta-D-allo-hept-5- ynofuranosyl)adenine: a selective and potent ligand for P3 purinoceptor-like protein.
Matsuda A; Kosaki H; Saitoh Y; Yoshimura Y; Minakawa N; Nakata H
J Med Chem; 1998 Jul; 41(15):2676-8. PubMed ID: 9667957
[No Abstract] [Full Text] [Related]
5. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910
[TBL] [Abstract][Full Text] [Related]
6. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.
Klotz KN; Camaioni E; Volpini R; Kachler S; Vittori S; Cristalli G
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):103-8. PubMed ID: 10494877
[TBL] [Abstract][Full Text] [Related]
7. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
[TBL] [Abstract][Full Text] [Related]
8. 2-alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors.
Vittori S; Camaioni E; Di Francesco E; Volpini R; Monopoli A; Dionisotti S; Ongini E; Cristalli G
J Med Chem; 1996 Oct; 39(21):4211-7. PubMed ID: 8863798
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.
Gallo-Rodriguez C; Ji XD; Melman N; Siegman BD; Sanders LH; Orlina J; Fischer B; Pu Q; Olah ME; van Galen PJ
J Med Chem; 1994 Mar; 37(5):636-46. PubMed ID: 8126704
[TBL] [Abstract][Full Text] [Related]
10. 2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
Cristalli G; Volpini R; Vittori S; Camaioni E; Monopoli A; Conti A; Dionisotti S; Zocchi C; Ongini E
J Med Chem; 1994 May; 37(11):1720-6. PubMed ID: 8201607
[TBL] [Abstract][Full Text] [Related]
11. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
Link AA; Kino T; Worth JA; McGuire JL; Crane ML; Chrousos GP; Wilder RL; Elenkov IJ
J Immunol; 2000 Jan; 164(1):436-42. PubMed ID: 10605040
[TBL] [Abstract][Full Text] [Related]
12. New substituted 9-alkylpurines as adenosine receptor ligands.
Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
[TBL] [Abstract][Full Text] [Related]
13. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
14. 2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
Cristalli G; Camaioni E; Vittori S; Volpini R; Borea PA; Conti A; Dionisotti S; Ongini E; Monopoli A
J Med Chem; 1995 Apr; 38(9):1462-72. PubMed ID: 7739005
[TBL] [Abstract][Full Text] [Related]
15. Effect of 9-(6,7-dideoxy-beta-D-allo-hept-5-ynofuranosyl)adenine on noradrenaline release from vascular sympathetic nerves.
Shinozuka K; Ishii-Nozawa R; Takeuchi K; Minakawa N; Matsuda A; Nakata H; Kunitomo M
Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):312-4. PubMed ID: 11251646
[TBL] [Abstract][Full Text] [Related]
16. 5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors.
de Zwart M; Kourounakis A; Kooijman H; Spek AL; Link R; von Frijtag Drabbe Künzel JK; IJzerman AP
J Med Chem; 1999 Apr; 42(8):1384-92. PubMed ID: 10212124
[TBL] [Abstract][Full Text] [Related]
17. Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.
Smith AD; Cheek DJ; Buxton IL; Westfall DP
Clin Exp Pharmacol Physiol; 1997 Jul; 24(7):492-7. PubMed ID: 9248666
[TBL] [Abstract][Full Text] [Related]
18. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
Olsson RA; Kusachi S; Thompson RD; Ukena D; Padgett W; Daly JW
J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and binding affinity of 3'-fluoro analogues of Cl-IB-MECA as adenosine A3 receptor ligands.
Lim MH; Kim HO; Moon HR; Lee SJ; Chun MW; Gao ZG; Melman N; Jacobson KA; Kim JH; Jeong LS
Bioorg Med Chem Lett; 2003 Mar; 13(5):817-20. PubMed ID: 12617898
[TBL] [Abstract][Full Text] [Related]
20. 2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes.
Wanner MJ; Von Frijtag Drabbe Künzel JK; Ijzerman AP; Koomen GJ
Bioorg Med Chem Lett; 2000 Sep; 10(18):2141-4. PubMed ID: 10999489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
